BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20438404)

  • 1. Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration.
    Samaratunga H; Samaratunga D; Perry-Keene J; Adamson M; Yaxley J; Delahunt B
    Pathology; 2010 Jun; 42(4):330-3. PubMed ID: 20438404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy.
    Freedland SJ; Aronson WJ; Presti JC; Amling CL; Terris MK; Trock B; Kane CJ
    Cancer; 2004 Apr; 100(8):1633-8. PubMed ID: 15073850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients.
    Zlotta AR; Roumeguère T; Ravery V; Hoffmann P; Montorsi F; Türkeri L; Dobrovrits M; Scattoni V; Ekane S; Bollens R; Vanden Bossche M; Djavan B; Boccon-Gibod L; Schulman CC;
    Eur Urol; 2004 Jul; 46(1):42-9. PubMed ID: 15183546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
    Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
    Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
    Ferrari MK; McNeal JE; Malhotra SM; Brooks JD
    Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for preoperative seminal vesicle biopsies in staging of clinically localized prostatic cancer.
    Guillonneau B; Debras B; Veillon B; Bougaran J; Chambon E; Vallancien G
    Eur Urol; 1997; 32(2):160-5. PubMed ID: 9286646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer.
    Linzer DG; Stock RG; Stone NN; Ratnow R; Ianuzzi C; Unger P
    Urology; 1996 Nov; 48(5):757-61. PubMed ID: 8911521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens.
    May M; Kaufmann O; Hammermann F; Loy V; Siegsmund M
    BJU Int; 2007 Mar; 99(3):539-44. PubMed ID: 17155973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significance.
    Miyai K; Kristiansen A; Egevad L; Pina-Oviedo S; Divatia MK; Shen SS; Miles BJ; Ayala AG; Park YW; Ro JY
    Hum Pathol; 2014 Sep; 45(9):1805-12. PubMed ID: 24993314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seminal vesicle amyloidosis does not provide any protection from invasion by prostate cancer.
    Erbersdobler A; Kollermann J; Graefen M; Röcken C; Schlomm T
    BJU Int; 2009 Feb; 103(3):324-6. PubMed ID: 18778344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current value of seminal vesicle biopsy in patients with prostate cancer and influence of radical prostatectomy in patients with seminal vesicle invasion].
    Losa CA; Fernando AB; Lázaro VA; Berlanga FF; Frago PS; López MA; Sanz MJ; Martínez PG; Sanz LA
    Arch Esp Urol; 2006 Dec; 59(10):977-88. PubMed ID: 17283711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
    Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
    Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A; Tareen B; Lepor H
    Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles.
    Johnson CW; Anastasiadis AG; McKiernan JM; Salomon L; Eaton S; Goluboff ET; Olsson CA; Benson MC
    Urol Oncol; 2004; 22(2):107-11. PubMed ID: 15082006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors.
    Bloom KD; Richie JP; Schultz D; Renshaw A; Saegaert T; D'amico AV
    Urology; 2004 Feb; 63(2):333-6. PubMed ID: 14972484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
    J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.